Related Experiment Videos
Pathogenic Ubqln2 gains toxic properties to induce neuron death
Qinxue Wu1, Mujun Liu, Cao Huang
1Department of Pathology, Thomas Jefferson University, JAH506, 1020 Locust Street, Philadelphia, PA, 19107, USA.
Acta Neuropathologica
|November 13, 2014
Summary
Mutations in ubiquilin 2 (Ubqln2) cause neurodegeneration through a gain of function. Ubqln2 overexpression with mutations leads to cognitive deficits and neuronal loss, unlike in knockout models.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mutations in ubiquilin 2 (Ubqln2) are associated with neurodegenerative diseases like amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
- Understanding the pathogenic mechanisms of Ubqln2 mutations, specifically gain-of-function versus loss-of-function, is crucial for disease research.
Purpose of the Study:
- To investigate the pathobiology of Ubqln2 and differentiate between gain-of-function and loss-of-function mechanisms in neurodegeneration.
- To establish and characterize novel Ubqln2 transgenic and knockout rat models for studying Ubqln2-related disorders.
Main Methods:
- Generation of Ubqln2 transgenic rats overexpressing a pathogenic P497H mutation and Ubqln2 knockout rats.
- Phenotypic analysis of the rat models, including cognitive assessments, neuronal loss evaluation, and examination of Ubqln2 aggregate formation.
- Biochemical analysis of autophagy substrates (p62, LC3-II) and endosome pathway function.
Main Results:
- Transgenic rats overexpressing mutated Ubqln2 (P497H) exhibited cognitive deficits and neuronal loss by 130 days.
- Neuronal loss in transgenic rats was associated with progressive Ubqln2 aggregate formation, p62 and LC3-II accumulation, and impaired endosome pathways.
- Ubqln2 knockout rats did not display these pathologies, even at 300 days of age.
Conclusions:
- Pathogenic Ubqln2 mutations appear to cause neuron death primarily through a gain of function, rather than a loss of normal Ubqln2 physiological functions.
- The novel Ubqln2 rat models provide valuable tools for further dissecting the molecular mechanisms underlying Ubqln2-associated neurodegenerative diseases.